Duke and the Harvard-MIT Center for Regulatory Science Anticancer Drug Development Workshop for Patient Advocates will focus on how advocates can work more effectively with all stakeholders in the research process – industry, academia, government and technology – to ensure that the patient voice is incorporated across all conversations and decision making. The mission of the course is to introduce patient advocates to the U.S. Food and Drug Administration’s drug development and approval process. We believe that educating advocates on the various methods involved in drug development will help them understand the process and be better prepared to participate in projects that help accelerate cancer drug treatments. The inclusion of informed advocates (including patients and caregivers) as equal stakeholders will add urgency and critical perspectives to the conversations. We believe the patient perspective is essential to the drug development process and are proud to help bring the patient voice to these important discussions.
Advocates attend both days of the Workshops. Day 1 will focus on the patient advocate, and the focus for day 2 will be on working with the investigator.
Scholarships covering accommodations at the Le Méridien Cambridge-MIT Hotel for patient advocates traveling from outside the Boston area are no longer available.
No charge to attend for patient advocates. Advocates must be affiliated with a national or regional advocacy organization, or be involved in the conduct, oversight or development of oncology clinical trials.